Meg specialises in U.S. corporate and securities law, advising on, among other things, general corporate matters and venture capital financing transactions, particularly in the life sciences sector.
Meg's day-to-day work focuses on advising life sciences and technology companies at all stages of development, with a particular focus on advising both companies and investors in venture capital financing transactions, from early-stage to late-stage. She also works closely with entrepreneurs to counsel them through initial company formation issues, day-to-day corporate governance matters, and liquidity events.
Prior to joining Taylor Wessing, she spent 10 years at a top-tier firm in California, where she represented prominent U.S. and international companies and funds in life sciences and technology financing transactions and exits. She is a current member of the California Bar.
Meg particularly enjoys advising clients on complex U.S. and cross-border venture financing transactions.
Represented client utilizing a generated AI discovery platform in oversubscribed financing round with multiple strategic and institutional investors
Represented U.S. medical imaging software and device company in late-stage financing round
von Dannie Hanna und Ross McNaughton
von Dr. Daniel Tietjen und Daniel Dietrich
von mehreren Autoren
von mehreren Autoren
von mehreren Autoren
von mehreren Autoren
von mehreren Autoren
von Dr. Amir-Said Ghassabeh und Dr. David Klein, LL.M. (Univ. of Washington), CIPP/E
von mehreren Autoren
von mehreren Autoren